文献速递食管胃疾病与幽门螺杆菌消化内镜

胃食管反流病患者接受长期抑酸治疗或抗反流手术后食管鳞状上皮「正常化」过程的动态变化

The dynamics of the oesophageal squamous epithelium 'normalisation' process in patients with gastro-oesophageal reflux disease treated with long-term acid suppression or anti-reflux surgery.
PubMed 文献 · Aliment Pharmacol Ther · 2017-03-21

LOTUS试验纳入554例慢性胃食管反流病患者,随机接受埃索美拉唑(每日20-40 mg)或腹腔镜抗反流手术,5年后372例仍在研究中(埃索美拉唑192例,手术180例)。结果显示两组在Z线和其上2 cm处所有指标在5年内逐渐改善,严重度评分和Ki-67表达较基线下降(P < 0.001),5年时达正常水平,两组间无显著差异。

要点

  • 慢性胃食管反流病患者接受抑酸或抗反流手术5年后鳞状上皮形态和增殖才「正常化」。
  • 两组严重度评分和Ki-67表达均较基线下降(P < 0.001),5年时达正常水平。
  • 埃索美拉唑治疗与腹腔镜抗反流手术间无显著差异。

核心结论

  • 慢性胃食管反流病患者尽管内镜和症状得到控制,鳞状上皮细胞形态和增殖「正常化」通常需要5年治疗。
  • 控制反流物中的酸成分似乎在恢复组织形态中起主要作用。

研究设计与样本

  • LOTUS试验中554例慢性胃食管反流病患者随机接受埃索美拉唑(每日20-40 mg)或腹腔镜抗反流手术(LARS)。
  • 5年后372例仍在研究中(埃索美拉唑192例,LARS 180例)。
  • 在基线、1年、3年和5年于Z线和其上2 cm处取活检,计算严重度评分(基于乳头延长、基底细胞增生、细胞间隙扩张和嗜酸性粒细胞浸润),并用Ki-67免疫组化评估上皮增殖活性。

主要发现

  • 两组在Z线和其上2 cm处所有指标在5年内逐渐改善。
  • 两组严重度评分在每个后续时间点均较基线下降(P < 0.001,所有比较),5年时达正常水平。
  • Ki-67表达相应下降(P < 0.001,所有比较)。
  • 埃索美拉唑治疗与LARS间未发现显著差异。
  • 基线严重度评分和Ki-67表达均不能预测治疗失败风险。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Proton pump inhibitors and laparoscopic anti-reflux surgery (LARS) offer long-term symptom control to patients with gastro-oesophageal reflux disease (GERD). AIM: To evaluate the process of 'normalisation' of the squamous epithelium morphology of the distal oesophagus on these therapies. METHODS: In the LOTUS trial, 554 patients with chronic GERD were randomised to receive either esomeprazole (20-40 mg daily) or LARS. After 5 years, 372 patients remained in the study (esomeprazole, 192; LARS, 180). Biopsies were taken at the Z-line and 2 cm above, at baseline, 1, 3 and 5 years. A severity score was calculated based on: papillae elongation, basal cell hyperplasia, intercellular space dilatations and eosinophilic infiltration. The epithelial proliferative activity was assessed by Ki-67 immunohistochemistry. RESULTS: A gradual improvement in all variables over 5 years was noted in both groups, at both the Z-line and 2 cm above. The severity score decreased from baseline at each subsequent time point in both groups (P < 0.001, all comparisons), attaining a normal level by 5 years. Corresponding decreases in Ki-67 expression were observed (P < 0.001, all comparisons). No significant differences were found between esomeprazole treatment and LARS. Neither baseline severity score nor Ki-67 expression predicted the risk of treatment failure. CONCLUSIONS: Five years of treatment is generally required before squamous epithelial cell morphology and proliferation are 'normalised' in patients with chronic GERD, despite endoscopic and symptomatic disease control. Control of the acid component of the refluxate seems to play the predominant role in restoring tissue morphology.

来源:Aliment Pharmacol Ther,查看原文。版权归原作者所有。

引用

  1. Mastracci L, Fiocca R, Engström C, et al. The dynamics of the oesophageal squamous epithelium 'normalisation' process in patients with gastro-oesophageal reflux disease treated with long-term acid suppression or anti-reflux surgery. Aliment Pharmacol Ther. 2017. PMID: 28326569. doi:10.1111/apt.14038

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。